SCHEMBL30526584

SCHEMBL30526584

COCCOc1ccc2nc(N)sc2n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 7/20 0.57
▸ PI4KA P42356 7/20 0.57
▸ PI4KB Q9UBF8 7/20 0.57
▸ PIK3CG P48736 6/20 0.57
▸ PIK3CD O00329 6/20 0.57
▸ PIK3CB P42338 6/20 0.57
▸ PIP5K1C O60331 1/20 0.41
▸ CYP3A4 P08684 4/20 0.39
▸ TSHR P16473 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ IKBKB O14920 1/20 0.38
▸ FTO Q9C0B1 2/20 0.36
▸ ALKBH5 Q6P6C2 1/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1851900 0.83 PIK3CD (0.45) PIK3CAPI4KAPI4KBPIK3CGPIK3CD
SCHEMBL2669105 0.83 PIK3CD (0.43) PIK3CAPI4KAPI4KBPIK3CGPIK3CD
SCHEMBL2666814 0.83 PI4KA (0.58) PIK3CAPI4KAPI4KBPIK3CGPIK3CD
SCHEMBL30526543 0.83 PIK3CD (0.55) PIK3CAPI4KAPI4KBPIK3CGPIK3CD
SCHEMBL184566 0.83 PIK3CD (0.55) PIK3CAPI4KAPI4KBPIK3CGPIK3CD
SCHEMBL10233444 0.82 HTR7 (0.46) PIK3CAPI4KAPI4KBPIK3CGPIK3CD
SCHEMBL3512062 0.82 PIK3CD (0.41) PIK3CAPI4KAPI4KBPIK3CGPIK3CD
SCHEMBL13408569 0.81 PIK3CD (0.40) PIK3CAPI4KAPI4KBPIK3CGPIK3CD
SCHEMBL10233497 0.81 PIK3CD (0.40) PIK3CAPI4KAPI4KBPIK3CGPIK3CD
SCHEMBL184747 0.80 PIK3CD (0.50) PIK3CAPI4KAPI4KBPIK3CGPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250026766-A1 Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta Inhibitors BEIGENE, LTD. (KY) 2025-01-23 — — US disclosed
EP-4463456-A1 THIAZOLOPYRIDYL AMIDE DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS BeiGene, Ltd. (KY) 2024-11-20 — — EP disclosed
WO-2024230578-A1 CYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2024-11-14 — — WO disclosed
CN-118510778-A Thiazolopyridylamide derivatives as inhibitors of DNA polymerase θ 百济神州有限公司 2024-08-16 — — CN disclosed
WO-2023134708-A1 THIAZOLOPYRIDYL AMIDE DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS BEIGENE , LTD. (KY) 2023-07-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026766-A1 Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta Inhibitors POLQ, POLK, POLI PIK3CA 386/4885PI4KA 134/4885PI4KB 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback